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Abstract: A common feature of lung disorders with poor treatment options, including emphy-
sema, is a failure to initiate a repair process of the alveolar epithelium. Several putative stem 
cell niches in the lung thought to be involved in lung homeostasis have been described. Appar-
ently, under pathophysiological conditions these resident progenitor cells are unable to recover 
damaged alveolar epithelium, in particular in emphysema. The potential therapeutic effect of 
retinoic acid receptor agonists on various resident lung progenitor cells is reviewed. 
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Stem cells
Stem cells can be deﬁ  ned as undifferentiated cells with a long life-span, which maintain 
the capacity to proliferate and maintain their own progenitor population. They produce 
a large number of differentiated daughter cells and form new tissue after injury. They 
generally reside in speciﬁ  c anatomical localizations, termed stem niches. 
Tracheal stem cells
The lung can be subdivided into three regions for the classiﬁ  cation of local stem 
cells (Figure 1). Tracheal stem cells originate from tracheal lining epithelial cells and 
tracheal gland duct cells. 
Depuit and colleagues (2000) investigated cell proliferation and differentiation 
in a model of tracheal xenograft in rats. Denuded rat tracheae were implanted with 
human airway epithelial cells. Two to four weeks after implantation, the rat tracheae 
had repopulated with human airway epithelial cells. Cytokeratin (CK) 13 was detected 
in all epithelial cells whereas CK14 expression was limited to basal cells. CK18 
was found in superﬁ  cial cells only. High CK expression is associated with stem cell 
potential. After four to ﬁ  ve weeks, the pseudostratiﬁ  ed columnar epithelium covered 
the entire surface of rat epithelium and resembled fully differentiated human airway 
epithelium. Proliferating cells consisted of basal or epithelial cells.
Investigation of tracheal epithelium after tracheal injury in rats, induced by ﬂ  uo-
rouracil (5-FU), was found to yield cells with naked nuclei located on the basement 
membrane of the trachea (Ding et al 2004). These cells proliferate and differentiate to 
restore the tracheal epithelium and are thought to represent tracheal stem cells. 
Hong and colleagues (2004a) also concluded that basal cells in the trachea are 
capable of restoring a fully differentiated epithelium. Liu and colleagues (1994) used 
tracheal grafts to search for progenitor cells and their results suggest that both basal 
and secretory cells dedifferentiated into a highly proliferative phenotype and then 
redifferentiated to form mucocilliary epithelium. 
Pulmonary neuroendocrine cells (PNECs) are thought to reside in niches associated 
with stem cells, which protect the cells from external damage. In mice, gland ducts in 
the trachea form such niches, as do foci near the cartilage – intercartilage junction in International Journal of COPD 2007:2(2) 132
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the distal epithelium. Due to the slow cycling of stem cells, it 
is necessary to damage airway epithelium to induce mitoses. 
Tracheal stem cells labelled with BrdU (5-bromo-2-deoxy-
uridine), a base analogue of thymidine, retain the label longer 
than other cells as a result of their slow cycle (Borthwick et al 
2001). The investigators used two methods to damage the epi-
thelium: intra-tracheal instillation of the detergent polidocanol, 
and SO2 inhalation. The results achieved for both methods of 
injury were similar. At day 21 and 95 after injury, the most 
densely BrdU staining cells were located at the submucosal 
gland ducts in the proximal trachea. Clusters were also found 
in the distal trachea, corresponding to the position of the car-
tilage- inter-cartilage junction. Tests conﬁ  rmed that although 
there is an association between the label-retaining cells (LRCs) 
and PNECs, not all LRCs were in fact PNECs.
Bronchiolar stem cells
The terminal bronchiole is highly resilient; it is capable of 
rapid renewal of the cell population in response to epithelial 
injury and cell depletion. 
Bronchiolar stem cells are difﬁ  cult to detect, as there is 
not yet a satisfactory stem cell marker as there is for skin 
epidermis and hemato-leukopoietic tissue (Coller et al 2005). 
However, bronchiolar progenitor cells have been identiﬁ  ed 
using a variety of labelling techniques in the steady state 
lung and in the lung after mechanical injury. It has now 
been established that these cells include basal cells and 
(nonciliated) Clara (Clara cell secretory protein (CCSP)-
expressing [CE]) cells (Hong et al 2004b). Clara cells may 
be the principal progenitor for the renewal of lung tissue 
(Figure 1). CE cells can be subdivided further according to 
Figure 1 Computed tomography-derived human tracheo-bronchial tree. In the trachea (site 1) three types of cells may execute the function of stem cell, including 
basal cells, secretory cells and neuro-endocrine cells. In the bronchial and bronchiolar compartment (site 2) suprabasal, basal and Clara cells have similar abilities. In the 
bronchiolar-alveolar compartment (site 3), type II pneumocytes and bronchoalveolar stem cells may function as stem cell.International Journal of COPD 2007:2(2) 133
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their susceptibility to naphthalene. Naphthalene-sensitive 
cells are more numerous than naphthalene-resistant cells, 
which have stem cell properties. CE cell injury, however, 
is resolved by recruitment of a second type of progenitor 
cell, known as a GSI-B4 (Griffonia simplicifolia isolectin) 
reactive, cytokeratin-14-expressing basal cell. 
To study the role of basal cells in bronchial epithelial 
regeneration, ganciclovir (GCV) or naphthalene (which 
speciﬁ  cally depletes CE cells), was administered to mice. 
Investigation of their bronchial epithelium after sacriﬁ  ce, 
showed that CE cells were the preferred progenitor cell for 
maintenance and regeneration of the airway epithelium and 
that basal cells were activated in response to the depletion 
of CE cells. 
Aurélie Avril-Delplanque and colleagues (2005) tested 
airway epithelial cells for various cell surface antigens and 
found that aquaporin-3 (AQP-3) water channel expression 
at the cell surface is limited to basal cells. Both AQP-3+ and 
AQP-3– suprabasal cells are capable of restoring mucosa. 
However, AQP-3– cells do so much more quickly than their 
AQP-3+ counterparts. At four weeks, AQP-3– cells had 
formed a pseudo-stratiﬁ  ed epithelium, whereas the AQP-3+ 
cells had formed a bilayered, poorly differentiated epithe-
lium. The authors state that it will be important to investigate 
whether the AQP-3– epithelial progenitors are secretory 
cells, as secretory cells have, in rat models, been shown to 
repopulate surface epithelium in four weeks.
West and colleagues (2001) discovered that Clara cells 
in mice are extremely sensitive to naphthalene compared 
to those of rats. The extent of injury is related to the dose 
and method of administration. At low doses, the proximal 
airway is mainly affected, whereas at high doses, the termi-
nal airways were also affected. At high doses (400 mg/kg), 
both Clara cells and ciliated cells were damaged in mice. In 
denuded areas, clusters of three to four, apparently undam-
aged cells were observed. The clusters appeared to be ciliated 
cells and were not distributed according to any anatomical 
area such as branch points. The investigators administered 
inhaled naphthalene to determine whether cells at branch 
points are more resistant to naphthalene injury as had been 
suggested. They concluded that cells at branch points are 
equally affected by naphthalene as cells at other anatomical 
locations. 
Giangreco and colleagues (2002) demonstrated the exis-
tence of a CE cell which functions as a stem cell and resides 
in the NEB (Neuro Endocrine Body) microenvironment of 
the bronchiolar epithelium. These CE cells are resistant to 
naphthalene injury. The investigators determined in which 
areas of terminal bronchiolar epithelium resistant CE cells 
reside. The phenotype of pollutant-resistant cells was 
assessed by dual-color ﬂ  uorescence immunostaining for the 
Clara cell-speciﬁ  c marker or the pulmonary neuroendocrine 
cell (PNEC)-speciﬁ  c marker calcitonin gene-related peptide. 
Clusters of resistant CE cells were found to reside adjacent 
to NEBs and a second population of resistant CE cells 
was located adjacent to the bronchoalveolar duct junction 
(BADJ). Further investigation using in situ hybridization 
and autoradiography conﬁ  rmed that the second population 
consists of CE cells. 
Naphthalene sensitivity is associated with high levels of 
cytochrome-450 2F2, which is responsible for the metabolism 
of naphthalene (Buckpitt et al 1995). Buckpitt investigated 
naphthalene metabolic rates in airway epithelium of mice, 
rats and hamsters and found mice to have a relatively high rate 
which explains their extreme sensitivity to naphthalene. 
Alveolar stem cells
An adult has on average 300,000 alveoli which are lined by 
three cell types (Berne et al 2004). Type I epithelial cells 
are responsible for gas exchange and have also been found 
to express genes which suggest that these cells play a role 
in maintenance of alveolar homeostasis, tumor suppression, 
lung development, and remodeling and surfactant metabolism 
(Dahlin et al 2004). These cells are extremely ﬂ  at and occupy 
95% of the surface area of the alveolus. Due to the highly 
attenuated cytoplasm, these cells are difﬁ  cult to isolate for 
study. Depletion of Type I pneumocytes by cytotoxic agents 
leaves the epithelial surface denuded. 
Type II epithelial cells are small cuboidal cells which 
usually reside in the corners of the alveolus, covering 
roughly 2% of the alveolar surface area. Type II pneumocytes 
are known to produce surfactant and regenerate alveolar 
epithelium after injury.
In healthy lungs, type I and type II cells exist in a 1:1 
ratio. 
Type III pneumocytes or brush cells, were reported 
throughout the lung in close proximity to unmyelinated 
nervous ﬁ  bres and are thought to function as chemoreceptors 
(Foliguet and Grignon 1980). 
It has long been established that type I pneumocytes are 
derived from type II pneumocytes. Evans and colleagues 
(1974) exposed male rats to NO2 to induce airway epithelial 
cell division. 3H-TdR was used to label dividing cells, most 
of which was taken up by type II pneumocytes. After two 
days, a large increase in the number of labelled type I cells 
had occurred, which remained stable up to day 14. These International Journal of COPD 2007:2(2) 134
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results strongly suggest that type I cells are derived from 
type II cells. 
Bender Kim and colleagues (2005) isolated pulmonary 
stem cell populations located at the bronchoalveolar duct 
junction which they termed bronchoalveolar stem cells 
(BASCs). BASC incidence was found to increase following 
intranasal bleomycin administration suggesting that they play 
a role in the response to alveolar damage.
Side population cells
Side population (SP) cells are a rare, primitive type of stem 
cell, recently discovered in the lung. SP cells have previ-
ously been identiﬁ  ed in other tissues and organs such as the 
bone marrow, kidney, liver, brain, heart, and small intestine. 
They can be identiﬁ  ed by their capability to efﬂ  ux Hoechst 
33342 dye (Majka et al 2005). SP cells do not have mark-
ers of differentiated cells but do express some early lineage 
commitment. This may be explained by the diversity of dif-
ferent lineages in the lung into which SP cells are capable 
of differentiating. 
Summer and colleagues (2003) found that SP cells 
comprise 0.03%–0.07% of total lung cells and are evenly 
distributed throughout the lung. All SP cells carry stem cell 
antigen (Sca)-1 but are lineage marker negative, conﬁ  rming 
that they are not differentiated. SP cells are positive for breast 
cancer resistance protein (BCRP) 1, a protein responsible for 
the ATP-mediated efﬂ  ux of Hoechst 33342 dye. Liang and 
colleagues (2005) investigated the gene expression proﬁ  le 
of CD45– and CD45+ SP cells (CD45 is a haematopoietic 
marker) and identiﬁ  ed 31 and 44 highly expressed genes 
respectively. SP cells from mouse embryos were separated 
from main population (MP) cells and the cells were split into 
four groups: SP CD45–, SP CD45+, MP CD45–, and MP 
CD45+. Gene proﬁ  ling data suggest that SP CD45– cells are 
involved in vascular development, whereas SP CD45+ cells 
may be progenitors for differentiated resident lung cells of 
myeloid lineage. 
Investigators have stressed the importance of establishing 
a uniform protocol for the isolation of SP cells in order to 
ensure the comparative nature of studies. The multi-step pro-
cess of isolating SP cells allows for a large inter-researcher 
variability. Factors include the concentration of Hoechst dye 
used, staining conditions and calibration of equipment.
Exogenous stem cells
The prospects of the use of exogenous stem cells to regen-
erate damaged and diseased tissues and organs are very 
exciting.
Bone marrow derived stem cells can be divided into ﬁ  ve 
groups: hematopoietic stem cells (HSCs), mesenchymal 
stem cells (MSCs), endothelial stem/progenitor cells (EPCs), 
SP cells, and multipotent adult progenitor cells (MAPCs). 
HSCs have been extensively studied and have been found 
responsible for the maintenance of circulating blood cell 
population. 
Various studies have been conducted in which engraft-
ment of bone marrow derived cells after lethal irradiation has 
been investigated. Theise and colleagues (2002) irradiated 
female mice thus inducing pneumonitis and injected them 
with bone marrow cells from male mice. Female mice were 
sacriﬁ  ced at various times and ﬂ  uorescence in situ hybrid-
ization (FISH) was used to detect donor-derived cells with 
a Y chromosome in lung tissue. Immunohistochemistry for 
cytokeratin 7 and 8 was performed to identify pneumocytes. 
Y-chromosomes were found in type II pneumocytes, showing 
that bone marrow cells can act as alveolar stem cells. 
Beckett and colleagues (2005) sought to compare various 
mechanisms of lung injury (which consequently stimulate 
different inﬂ  ammatory signalling cascades) and the patterns 
of lung engraftment they induced. Irradiated female mice 
were subjected to either intranasal endotoxin or inhaled NO2 
one month after administration of bone marrow derived donor 
cells from male mice. The investigators concluded that there 
was no signiﬁ  cant difference between the numbers of donor-
derived type II pneumocytes in the lung in mice which had 
been irradiated compared to mice which had been irradiated 
and had received either endotoxin or NO2. The majority of 
donor-derived cells found in the lung were leucocytes rather 
than epithelial cells. Although the engraftment patterns were 
different for inﬂ  ammatory cells, the two methods of injury did 
not result in varying patterns of engraftment of lung epithelial 
cells. The investigators state that the paucity donor-derived 
epithelial cells in the lung may be due to the lower dose of 
irradiation used.
Gomperts and colleagues (2006) demonstrated that early 
epithelial marker cytokeratin 5 (CK5) and the chemokine 
receptor CXCR4 are markers of epithelial progenitors in the 
circulation or bone marrow. The CXCR4/CXCL12 biological 
axis is important in mobilizing and recruiting bone marrow 
derived cells to the site of injury in the lung.
Aliotta and colleagues (2006) investigated the effect of 
granulocyte colony stimulating factor (G-CSF) on irradiated 
mice that had received donor bone marrow cells. Mice treated 
with G-CSF had higher levels of donor marrow – derived 
lung cells compared to mice whose bone marrow cells had 
not been mobilized by G-CSF.International Journal of COPD 2007:2(2) 135
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Emphysema
Emphysema is one of the subtypes of COPD. The disease is 
deﬁ  ned as dilatation and destruction of lung tissue distal to 
the terminal bronchiole (Kumar and Clark 2002). It is widely 
accepted that the disease is caused by excessive proteolytic 
activity by elastases. Recent research has called for a broad 
interpretation of the protease-antiprotease hypothesis as 
many enzymes and their inhibitors, besides the initially found 
alpha-1-protease inhibitor, have been found to be involved 
in the pathogenesis of emphysema. 
Macrophages release two classes of elastolytic enzymes: 
cysteine proteinases (cathepsin L and cathepsin S) and 
several matrix metalloproteinases (MMPs). MMPs are 
proteolytic enzymes secreted in latent form, their activation 
is thought to be induced by oxidants from cigarette smoke 
(Gibbs et al 1999).
Neutrophil recruitment into the lung in response to ciga-
rette smoke is mediated by interleukin (IL) –8 secreted by 
alveolar epithelial cells (Witherden et al 2004). 
Cigarette smoke was found to induce recruitment of 
macrophages to alveoli in mice exposed to the smoke of 
nine cigarettes per day (da Hora et al 2005). Churg and 
colleagues (2004) demonstrated the role of tumor necrosis 
factor-α (TNF-α) in cigarette smoke-induced emphysema 
in mice. Mice, deﬁ  cient in TNF-α receptors, show neither 
matrix breakdown nor airspace enlargement in response to 
cigarette smoke. Their lungs contain fewer neutrophils than 
those of their nonsmoking counterparts. Western-blotting, 
used to detect levels of MMPs, showed that wild-type mice 
that had been exposed to smoke had higher levels for each 
of the detected MMPs than the TNF-α receptor deﬁ  cient 
mice. These results show that TNF-α is responsible for a 
signiﬁ  cant percentage of the processes that cause airspace 
enlargement; TNF-α drives the production of various MMPs 
in mouse models.
Interestingly, the investigators discovered that the 
65%–70% protection value yielded by knocking out the 
TNF-α receptor approximately corresponds to the protec-
tion values found in neutrophil elastase knockout mice. 
The detection of lower levels of MMPs in TNF-α receptor 
knockout mice does however suggest that these levels were 
induced by stimulation via an alternative pathway indepen-
dently of TNF-α. Churg and colleagues (2004) proposed 
apoptosis as a possible alternative pathway responsible for 
airway space enlargement.
Aoshiba and colleagues (2003) investigated the role of 
airway epithelial apoptosis in the pathogenesis of emphy-
sema. A single intratracheal injection of active caspase-3 and 
Chariot, a newly developed protein transfection reagent, was 
administered to mice to induce alveolar wall apoptosis. Six 
hours later, the lungs of sacriﬁ  ced mice showed focal airway 
enlargement and destruction of alveolar walls. Elastin was 
lost from alveolar walls and the lungs were more distensible 
than those of untreated animals. 
Emerging therapy for emphysema
Retinoic acid
Retinoic acid is the active metabolite of vitamin A (retinol), 
which is acquired from the diet and has many functions in 
cell development, differentiation, and homeostasis. All-
trans-retinoic acid (ATRA) is an analogue of vitamin A and 
its role in inducing alveolar regeneration has recently been 
under investigation due to its exciting potential as a therapy 
for diseases such as emphysema (Figure 2).
In 1987, the retinoic acid receptor was discovered 
(Chambon 1996). There are two types of retinoid receptor: 
retinoic acid receptors (RARs) and retinoid X receptors 
(RXRs). Three isoforms of the RAR are known, each of 
which has a different role during alveolar development 
(Figure 3). Massaro and colleagues (2003) found that RARα, 
one of the three RAR isoforms, is able to regulate alveolar 
development in mice at the age of 14–50 days. RARβ inhibits 
alveolar formation in the early post-natal period only. RARγ, 
the third isoform of RAR is necessary for formation of al-
veoli in mice during the ﬁ  rst 28 days after birth. Additional 
experiments showed that RARγ drives tropo-elastin gene 
expression (Figure 4; McGowan et al 2000) and that RARγ 
agonists promote alveolar repair in animals with experimen-
tally-induced emphysema (Massaro et al 1997).
Snyder and colleagues (2005) proposed that RARβ, plays 
an important role in neo natal alveolar growth. Mice lacking 
the RARβ gene were found to have impaired neonatal lung 
function. The area for gas exchange was smaller than that 
of their wild-type counterparts.
Experiments conducted by Cardoso and colleagues 
(1995) have shown that retinoids inﬂ  uence the developmental 
pattern of lung tissue in vitro. 
Fujita and colleagues (2004) treated mice with daily 
intraperitoneal ATRA injections for 12 days, following 
induction of emphysema with porcine pancreatic elastase. 
Histopathological analysis revealed no signiﬁ  cant difference 
between mice treated with ATRA and controls. 
Hind and Maden (2004) demonstrated that mice treated 
with dexamethason, which disrupts alveolar development, 
followed by retinoic acid (RA) administration had a more 
complex alveolar structure and more alveoli than control International Journal of COPD 2007:2(2) 136
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Figure 2 Retinoid acid receptor agonists (RAR agonists) are involved in the pathogenesis of chronic bronchitis due to excess activity of type β RAR agonists involved in 
mucus production and in the pathogenesis of emphysema when reduced activity of type γ RAR agonists is present.
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Figure 3 Type γ retinoid acid receptor is required for alveolar septation and branching morphogenesis. In this system, plasma retinol and retinol binding protein may have 
an important regulatory role in COPD.International Journal of COPD 2007:2(2) 137
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mice that had not received RA following dexamethason. 
Lungs of mice treated with both dexamethason and RA 
resembled those of mice who had received neither dexa-
methason or RA. 
However, experiments conducted with rat emphysema 
models showed that ATRA induced alveolar regeneration. 
Tepper and colleagues (2000) administered two doses of 
porcine elastase intratracheally to male rats. Nine weeks 
later, the rats were treated with daily intraperitoneal ATRA 
injections for 2 weeks. Elastase-induced airway obstruction 
worsened progressively in rats treated with elastase only, 
whereas rats treated with elastase followed by ATRA showed 
no progression of airway obstruction. CT scans showed that 
ATRA caused a restoration of lung density, which was not 
signiﬁ  cant, whereas rats treated with elastase only displayed 
a reduced density. There were, however, small but signiﬁ  cant 
changes in lung volume after two weeks of intraperitoneal 
RA infusions. 
Ishizawa and colleagues (2004) investigated the effect 
of G-CSF and ATRA on emphysema induced by elastase 
in mice. Combination of G-CSF and ATRA had an additive 
effect, indicating that mobilization of BMCs may play an 
important role in lung regeneration after injury. 
Nakajoh and colleagues (2003) investigated whether 
retinoic acid protects epithelial cells from elastase-induced 
damage and apoptosis. Three cell types were exposed to 
elastase and their viability was monitored following expo-
sure to various amounts of elastase. Retinoic acid without 
prior elastase treatment caused no change in the viability of 
the lung epithelial cells. Retinoic acid administered to cells 
damaged by elastase improved the viability of each of the 
three cells types. The investigators also found that pre-
treatment with retinoic acid, followed by elastase, improves 
cell viability signiﬁ  cantly.
Belloni and colleagues (2000) performed immunohisto-
chemistry on alveolar tissue. Within 24 hours of ATRA treat-
ment, they found a threefold increase in apoptotic cells in rats 
to which elastase had previously been administered compared 
with rats that had not received ATRA. These ﬁ  ndings suggest 
that ATRA induces apoptosis which is a normal part of the 
RAR Agonists Maintain Alveolar Elastin and Lung Elastic Recoil
Transcriptional Regulator of Matrix Proteins
Repression of MMP via AP-1
Transcriptional activation of TIMPS
Transcriptional activation of tropo-elastin
Normal Elastin
Elastin
fiber
Collagen
fiber
>>
>>
>>
relax
stretch

Figure 4 RARγ drives tropo-elastin gene expression. Tropo-elastin is the precursor of elastin, the later has a critical function in the elastic recoil of the lung. Destruction of 
elastin content in the lung will result in emphysema.International Journal of COPD 2007:2(2) 138
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wound-healing process in which speciﬁ  c cell populations are 
eliminated without inducing an inﬂ  ammatory response. 
Nabeyrat and colleagues (2000) found evidence that RA 
stimulates proliferation of type II alveolar cells. Their results 
show that RA acts on regulatory proteins in the cell cycle 
leading them to suggest that RA is capable of causing cells 
which have ceased proliferating to resume growth. 
A double blind, placebo-controlled trial, conducted 
by Mao and colleagues (2002) in which 20 patients with 
moderate to severe emphysema participated, showed that 
ATRA is well-tolerated by humans. Besides their usual 
therapy, patients received twice-daily doses of 25 mg/m2 
ATRA for four days a week for twelve weeks. Side effects 
included dry skin and cracked lips, headache, hyperlipidemia, 
mild pruritis, mild transaminase elevations, mild muscle and 
bone pain/soreness, and a sensation of clogged ears. The study 
did not show any reversal of emphysema.
Due to the side effects caused by long-term use of oral 
retinoid acid, Brooks and colleagues (2000) proposed the use 
of aerosolized ATRA as a safer alternative. Tests using rats 
revealed that intra-tracheal administration of ATRA resulted 
in a long half-life in the lung and low systemic levels, proving 
that aerosolized ATRA is a feasible therapy. 
The development of selective RARgamma agonists was 
taken forward by a pharmaceutical company and resulted 
in a large proof-of-concept study currently conducted in 20 
hospitals world-wide with the aim to proof that agonists of 
RARgamma are able to induce lung alveolar growth and 
improved gas exchange in patients with emphysema.
Conclusion
Despite signiﬁ  cant advances over the past decades, much 
remains unknown about the processes involved in lung 
epithelial repair. As our knowledge of lung physiology 
improves, new therapies will emerge for destructive diseases 
such as emphysema. 
Research into pulmonary stem cells has yielded valuable 
information concerning the origins and functions of stem 
cells at various anatomical locations, such as the trachea, 
bronchus and alveolus. It is thought that stem cells may 
hold the key to new treatments, possibly even a cure for 
emphysema.
Currently, further research and trials are being carried out 
to explore the use of retinoid acid receptor agonists, discussed 
in the second part of this review, as a potential therapy for 
emphysema. Hopefully these studies will yield useful data 
concerning the molecular signaling pathways involved in 
alveolar epithelial regeneration. 
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